ARTICLE | Finance
Ready to go solo
Achillion's $126 million follow-on prepares HCV play to go it alone
February 25, 2013 8:00 AM UTC
Investors hoping Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) would be taken out in the HCV gold rush might take last week's $126 million follow-on as a signal that the company now expects to go it alone for the foreseeable future.
In November 2011, President and CEO Michael Kishbauch told Bloomberg the company was in advanced discussions with potential partners and acquirers. The comment triggered an 8% jump in Achillion shares...